Modelling the Economic Burden of SARS-CoV-2 Infection in Health Care Workers in Four Countries
Overview
Authors
Affiliations
Health care workers (HCWs) experienced greater risk of SARS-CoV-2 infection during the COVID-19 pandemic. This study applies a cost-of-illness (COI) approach to model the economic burden associated with SARS-CoV-2 infections among HCWs in five low- and middle-income sites (Kenya, Eswatini, Colombia, KwaZulu-Natal province, and Western Cape province of South Africa) during the first year of the pandemic. We find that not only did HCWs have a higher incidence of COVID-19 than the general population, but in all sites except Colombia, viral transmission from infected HCWs to close contacts resulted in substantial secondary SARS-CoV-2 infection and death. Disruption in health services as a result of HCW illness affected maternal and child deaths dramatically. Total economic losses attributable to SARS-CoV-2 infection among HCWs as a share of total health expenditure ranged from 1.51% in Colombia to 8.38% in Western Cape province, South Africa. This economic burden to society highlights the importance of adequate infection prevention and control measures to minimize the risk of SARS-CoV-2 infection in HCWs.
Rispel L, Ditlopo P, White J, Blaauw D BMJ Open. 2024; 14(12):e089998.
PMID: 39645247 PMC: 11628963. DOI: 10.1136/bmjopen-2024-089998.
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS-CoV-2.
Fuochi V, Furnari S, Floresta G, Patamia V, Zagni C, Drago F Arch Pharm (Weinheim). 2024; 358(1):e2400545.
PMID: 39520338 PMC: 11704024. DOI: 10.1002/ardp.202400545.
Li X, Song Y J Med Chem. 2024; 67(21):18642-18655.
PMID: 39478665 PMC: 11787806. DOI: 10.1021/acs.jmedchem.4c01749.